ArticleFrontiers in nutrition2026
Dietitian-led individualized pancreatic enzyme replacement therapy is associated with favorable nutritional and immune-inflammatory profiles in pancreatic cancer: a retrospective cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic cancer is a highly malignant tumor with extremely poor prognosis. Pancreatic exocrine insufficiency (PEI), malnutrition, and immune-inflammatory dysfunction are highly prevalent and closely interact to impair postoperative recovery and clinical outcomes. Pancreatic enzyme replacement therapy (PERT) is the standard care for PEI; however, evidence regarding the association between dietitian-led individualized PERT and nutritional as well as immune-inflammatory profiles remains limited. Methods: This retrospective cohort study enrolled 123 patients with histologically confirmed pancreatic cancer who underwent surgical resection at Nanjing Drum Tower Hospital, affiliated to Nanjing University Medical School, from January 2018 to December 2023. Patients were retrospectively allocated to the Individualized PERT group ( Results: Dietitian-led individualized PERT was significantly associated with better preservation of body weight. The mean difference in weight change between the Individualized PERT and Standard PERT groups was 3.29 kg (95% CI: 1.32-5.27; Conclusion: In this retrospective cohort study, dietitian-led individualized PERT combined with nutritional counseling is independently associated with favorable nutritional and immune-inflammatory profiles among pancreatic cancer patients with PEI after adjusting for major confounders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.